Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

ClinicalTrials.gov ID: NCT04948307

Public ClinicalTrials.gov record NCT04948307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Parallel-group Study to Evaluate the Efficacy of the Digital Therapeutic OXD01 (MODIA™) in Combination With Sublingual Buprenorphine/Naloxone for the Treatment of Opioid Use Disorder

Study identification

NCT ID
NCT04948307
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Orexo AB
Industry
Enrollment
437 participants

Conditions and interventions

Interventions

  • OXD01 digital therapy Device
  • Standard of Care Other

Device · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2021
Primary completion
Apr 11, 2023
Completion
May 9, 2023
Last update posted
Jun 26, 2025

2021 – 2023

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Parkway Medical Center Birmingham Alabama 35215
North County Clinical Research Oceanside California 92054
Artemis Institute for Clinical Research San Diego California 92103
Wetlin Research Associates, Inc San Diego California 92120
Humanity Clinical Research Pembroke Pines Florida 33024
Southern Illinois Associates LLC Glen Carbon Illinois 62034
Otrimed Clinical Research Edgewood Kentucky 41017
Patient First Medical Clinic Dearborn Michigan 48126
Precise Research Centers Flowood Mississippi 39232
PsychCare Consultants Research St Louis Missouri 63128
Dr. Vando Medical Services PC The Bronx New York 10466
Midwest Clinical Research Center Dayton Ohio 45417
North Star Medical Research Middleburg Heights Ohio 44130
Neuro-Behavioral Clinical Research Center North Canton Ohio 44720
CincyScience West Chester Ohio 45069
Pahl Pharmaceuticals Professions Oklahoma City Oklahoma 73112
Thalia Medical Center Haverford Pennsylvania 19041
MD Medical Management Kingston Pennsylvania 18704
Medically Assisted Recovery Service Philadelphia Pennsylvania 19116
Institute of Addiction Medicine Plymouth Meeting Pennsylvania 19462
Aspen Clinical Research Orem Utah 84058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04948307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04948307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →